title: [Supervision after breast cancer treatment].
abstract: Breast cancer screening and therapeutic advances have significantly decreased breast cancer mortality. Nearly 80% of patients with a localized disease will experience a prolonged survival and the organization of their monitoring is critical to early detection of local or metastatic relapse. Annual mammography is recommanded for the follow up and no further imaging examination is routinely necessary. Early diagnosis of metastatic relapse has not demonstrated evidence of survival benefit. However, treatments are not without toxicities and data about long-term complications are missing. The socio-economic consequences for these patients need to be evaluated and cardiovascular toxicities of chemotherapy and hormonal therapy are probably underestimated.
authors.forename: Shanna
authors.initials: S
authors.lastname: Rajpar
authors.affiliation: Institut Gustave-Roussy, unité de recherche UPRES EA 3535, service de pharmacologie et nouveaux traitements des cancers, 94805 Villejuif Cedex, France.
authors.forename: Fabrice
authors.initials: F
authors.lastname: André
mesh_terms: D001943:Breast Neoplasms / Q000150:complications / Q000523:psychology / Q000628:therapy*; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000517:prevention & control; D017741:Survivors / Q000523:psychology